Picture of Sinopharm logo

1099 — Sinopharm News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Cuba to deploy China's Sinopharm alongside homegrown vaccines

By Sarah Marsh
    HAVANA, Aug 28 (Reuters) - Cuba, which to date had deployed
exclusively its homegrown COVID-19 vaccines, will start also
using the Sinopharm vaccine of its Communist-run ally China in
its bid to battle one of the worst coronavirus outbreaks in the
world.
    Health authorities will apply two doses of Sinopharm
combined with a Cuban booster in the central province of
Cienfuegos from Sunday, Vicente Verez, the head of the Cuban
Finlay Vaccine Institute, was cited as saying by the provincial
state-run outlet 5deSeptiembre.
    The efficacy of the vaccine combo is above 90%, according to
the outlet, without detailing where the data came from or
whether Cuba's drug regulator had authorized the use of the
Chinese vaccine. The World Health Organization gave emergency
approval to the Sinopharm shot in May.
    Authorities who had said earlier this month https://www.reuters.com/world/americas/cuba-says-early-data-suggests-homegrown-vaccine-protecting-against-delta-2021-08-13
 they would be able to produce enough vaccines for all of Cuba
by September did not explain why they were choosing to deploy a
foreign one now. 
    "It seems obvious the decision to apply Sinopharm in
Cienfuegos is associated to the limited availability of Cuban
vaccines and the urgency caused by the explosion of cases," said
Brazil-based Cuban virologist Amilcar Perez Riverol.
    The health ministry had said in May the plan was to have
vaccinated 70% of the population by August but had so far only
reached around 30%, said Perez Riverol, who has become a guru on
Cuban COVID-19 data analysis, on Facebook.
    Meanwhile, Cuba has one of the highest COVID-19 caseloads in
the world which is overwhelming https://www.reuters.com/world/americas/coronavirus-surge-pushes-cubas-healthcare-system-brink-2021-08-11
 its vaunted healthcare system which is heavily focused on
prevention and primary care.
    The outbreak comes amid a shortage of basic goods including
medicine that has fueled anger at the government, leading to
unprecedented nationwide protests https://www.reuters.com/world/americas/street-protests-break-out-cuba-2021-07-11
 last month.
    Cuban authorities, which blame the economic crisis largely
on a tightening of U.S. sanctions, have hailed donations https://www.reuters.com/world/americas/cuba-receives-food-medicine-donations-allies-ease-crisis-2021-07-31
 of medical gear and food since the protests from allies like
China although it was unclear if the vaccines were donated or
bought.
    
    TOO LATE?
    Government critics had long urged it to acquire foreign
vaccines rather than simply relying on homegrown ones, accusing
it of placing its desire for prestige and good publicity over
health concerns. Authorities said they preferred to focus scant
resources on vaccine development and production than imports.
     U.S. President Joe Biden said last month https://www.reuters.com/world/us/us-has-contingency-plans-if-it-faces-mass-migration-by-sea-cuba-official-2021-07-15
 the United States was prepared to send vaccines to Cuba if it
was assured an international organization would administer them.
    Cuban President Miguel Diaz-Canel retorted that if the
United States cared about the island's humanitarian situation,
it would lift the U.S. sanctions they accuse amongst other
things of slowing down production of its homegrown vaccines.
    The country has developed an unusually large biotech sector
for a country its size, partly in a bid for sovereignty given
the decades-old crippling U.S. trade embargo.
    It is the only Latin American country https://www.reuters.com/article/uk-health-coronavirus-vaccine-cuba-focus-idUKKBN27S1OZ
 to have completed the development of two COVID-19 vaccines,
Soberana 2 and Abdala, which have elicited interest from nations
worldwide from Jamaica and Mexico to Vietnam and Argentina. 
    It says the three shot vaccines both have efficacy of over
90% https://www.reuters.com/business/healthcare-pharmaceuticals/cuba-says-second-covid-vaccine-soberana-2-boasts-912-efficacy-2021-07-09
 although the data has not yet been published in peer-reviewed
journals. It has authorized both for emergency use https://www.reuters.com/world/americas/cuba-grants-emergency-approval-second-homegrown-vaccine-2021-08-21.

 (Reporting by Sarah Marsh; Additional Reporting by Nelson
Acosta
Editing by Marguerita Choy)
 ((sarah.marsh@thomsonreuters.com; +53 5217 0928; Reuters
Messaging: sarah.marsh.thomsonreuters.com@reuters.net))

Recent news on Sinopharm

See all news